VANCOUVER, British Columbia, Feb. 07, 2019 -- Chakana Copper Corp. (TSX-V: PERU; OTC: CHKKF; FWB: 1ZX) (the “Company” or “Chakana”), is pleased to release initial drill results from Breccia Pipe 6 (Bx 6) at the Soledad copper-gold-silver project in central Peru. Bx 6 is located 500 metres north of Bx 5 and 1 km northwest of Bx 1 and is the northernmost and highest elevation outcropping breccia pipe identified to date in the Soledad cluster. There are seventeen confirmed breccia pipes on the Soledad project, twelve of which occur in the Soledad cluster, along with twelve other targets with distinctive alteration that is consistent with the alteration encountered adjacent to breccia pipes in previous drilling (Fig. 1). Four of the seventeen confirmed pipes have been drilled to date.

ST. JOHN'S, Feb. 5, 2019  - Aurion Resources Ltd. (TSXV: AU) ("Aurion" or the "Company") is pleased to report new high-grade assay results in drilling at the Aamurusko prospect on its Risti Project in northern Finland.   

 

Highlights

 

Two of the first three 2019 drillholes intersected high-grade gold mineralization near surface

42.28 g/t Au over 4.00 mintersected in drillhole 82

24.50 g/t Au over 4.75 m intersected in drillhole 81, approximately 56 m east of drillhole 82

High-grade mineralization has now been encountered over an east-west distance of 56 m with a sub-vertical distance of 110 m, with mineralization still open

See News Release (C-HUGE) FSD Pharma Inc

 

PHARMA GRADE PROCESS COULD REDUCE THE PRODUCTION TIME FOR TARGETED CANNABINOID MOLECULE(S)

 

FSD Pharma Inc. (CSE: HUGE) (OTC: FSDDF) (“FSD Pharma”) and Solarvest BioEnergy Inc. (TSX-V: SVS) (“Solarvest”) (collectively, the “Parties”), a technology company which has developed an algal-based flexible production platform capable of producing health products, are pleased to announce that they have signed a non-binding letter of intent (“LOI”). The parties intend to enter into a definitive agreement (the “Collaborative Research Agreement”), under which Solarvest would conduct research using its algal expression technology to develop pharma-grade cannabinoids (the “Project Cannabinoids”), the Parties would make mutual investments into one another, and Solarvest would grant FSD Pharma an exclusive license over a subset of the Project Cannabinoids and certain royalty rights over all of the other Project Cannabinoids.

VANCOUVER, British Columbia, Feb. 01, 2019 -- Asanko Gold Inc. (“Asanko” or the “Company”) (TSX, NYSE American: AKG) is pleased to provide an update on the development of the Esaase Project, which forms part of the multi-pit Asanko Gold Mine (the “AGM”), located in Ghana, West Africa. The AGM is a 50:50 joint venture (“JV”) with Gold Fields Ltd (JSE, NYSE: GFI) which is managed and operated by Asanko.

 

Highlights:

 

Successful completion of Esaase bulk sampling in Q4 2018

Trial mining operations at Esaase commenced in January 2019, as planned

Mined 95,899 tonnes @ 1.2 g/t in January 2019 @ 0.5g/t cut off grade

Development decision by JV partners to proceed with Esaase development expected Q2 2019

Updated NI 43-101 expected in Q2 2019